Express Pharma
Home  »  Latest Updates  »  Orchid Pharma gets EIR from US FDA for its Alathur facility

Orchid Pharma gets EIR from US FDA for its Alathur facility

53
Read Article

The facility was inspected by the US FDA

Orchid Pharma has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tamil Nadu.

The company has received EIR from the United States Food and Drug Administration (US FDA) based on the successful inspection of the active pharmaceutical ingredients (API) manufacturing facility at Alathur. The facility was inspected by the US FDA, Orchid Pharma said in a filing to BSE.

Comments are closed.